Home › Funds › Clear Harbor Asset Management, LLC › ABT

Clear Harbor Asset Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Clear Harbor Asset Management, LLC reported holding 78,013 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 0.50% of its reported portfolio and ranking #45 among its reported holdings. Clear Harbor Asset Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)78.01K sh
Reported value held$7.71M
Portfolio Weight0.50%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Clear Harbor Asset Management, LLC's ABT position evolved

Clear Harbor Asset Management, LLC first disclosed a stake in ABT in Q3 2023 at 42,795 shares (US$4.1M). The position peaked in Q3 2026 at 78,013 shares, worth US$7.7M. Across 13 filings, Clear Harbor Asset Management, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 78,013 shares valued at US$7.7M — an increase of 24,139 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2026 (shares rose 10% over the following quarter), a 45% increase in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 42.80K $4.14M New
Q4 2023 46.55K $5.12M Add
Q1 2024 46.28K $5.26M Reduce
Q2 2024 50.78K $5.28M Add
Q3 2024 52.38K $5.97M Add
Q4 2024 51.85K $5.86M Reduce
Q1 2025 51.17K $6.79M Reduce
Q2 2025 48.79K $6.64M Reduce
Q3 2025 45.43K $6.08M Reduce
Q4 2025 41.38K $5.18M Reduce
Q1 2026 42.44K $4.36M Add
Q2 2026 53.87K $4.89M Add
Q3 2026 78.01K $7.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Clear Harbor Asset Management, LLC held ABT?

Clear Harbor Asset Management, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Clear Harbor Asset Management, LLC's current position in ABT?

As of Q3 2026, Clear Harbor Asset Management, LLC holds 78.01K shares of ABT (ABBOTT LABORATORIES), valued at $7.71M, representing 0.50% of its reported portfolio and ranking #45.

Has Clear Harbor Asset Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Clear Harbor Asset Management, LLC increased its position in ABT. The position peaked in Q3 2026 at 78.01K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.